Robert C. Robbins

Heart transplantation: a thirty-year perspective.

Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-beta1 ameliorates ischemia-reperfusion injury in rat cardiac allografts.

Zinc chloride-mediated reduction of apoptosis as an adjunct immunosuppressive modality in cardiac transplantation.

Alternative approach for use of a left ventricular assist device with a thrombosed prosthetic valve.

Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model.

VEGF gene delivery for treatment of ischemic cardiovascular disease.

Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the Stanford experience.

Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va.

The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts.

Does profound hypothermic circulatory arrest improve survival in patients with acute type a aortic dissection?

Absent secretion to vasoactive intestinal peptide in cystic fibrosis airway glands.

Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections?

Coronary atherosclerosis in cardiac transplant patients treated with total lymphoid irradiation.

Antisense oligonucleotides: design, construction, and applications to cardiac allograft transfer.

Novel index for invasively assessing the coronary microcirculation.

Antegrade versus retrograde perfusion of the donor lung: impact on the early reperfusion phase.

Elevated cyclic adenosine monophosphate ameliorates ischemia-reperfusion injury in rat cardiac allografts.

Long-term results of heart transplantation in patients older than 60 years.

对大鼠心脏移植氧化应激和移植冠状动脉疾病 bcl-2 腺病毒表达上调的影响。

Quantification of mechanical stabilization for the performance of off-pump coronary artery surgery.

Bcl-2-mediated inhibition of apoptosis in rat cardiac allografts worsens development of graft coronary artery disease.

Comparison of developmental endothelial locus-1 angiogenic factor with vascular endothelial growth factor in a porcine model of cardiac ischemia.

Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era.

Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation.

L-Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats.

Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve.

The impact of brain death on survival after heart transplantation: time is of the essence.

Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation.

Acute type A aortic dissection complicated by aortic regurgitation: composite valve graft versus separate valve graft versus conservative valve repair.

A few critical aspects--and Achilles heels--of tissue engineering approaches to restore injured myocardium.

Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.

Identifying cardiac transplant rejection in children: diagnostic utility of echocardiography, right heart catheterization and endomyocardial biopsy data.

Gastric pacing for severe gastroparesis in a heart-lung transplant recipient.

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium.

Distinct cell-to-fiber junctions are critical for the establishment of cardiotypical phenotype in a 3D bioartificial environment.

微创瓣膜置换术的确曾将重要吗？

Chylothorax after heart/lung transplantation.

Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation.

Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis.

Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease.

Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts.

Overexpression of human copper/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts.

Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle.

The road to clinical xenotransplantation: a worthwhile journey.

Superoxide dismutase mimetic m40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts.

Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration.

Pre-transplant blood transfusion and cyclosporin A induce long-term hamster cardiac xenograft survival in immunocompetent rats.

Successful repair of tracheal dehiscence after heart-lung transplantation.

Lung transplantation: a decade of experience.

Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment.

Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.

Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.

Overexpression of human Bcl-2 in syngeneic rat donor lungs preserves posttransplant function and reduces intragraft caspase activity and interleukin-1beta production.

Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction.

Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.

Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury.

Progression of alloresponse and tissue-specific immunity during graft coronary artery disease.

Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research.

Myocardial restoration with embryonic stem cell bioartificial tissue transplantation.

Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease.

Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation.

Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.

In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.

Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.

Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury.

Haematopoietic stem cells and repair of the ischaemic heart.

Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion.

Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 t.

Thoratec ventricular assist devices in pediatric patients: update on clinical results.

Allopurinol/uricase and ibuprofen enhance engraftment of cardiomyocyte-enriched human embryonic stem cells and improve cardiac function following myocardial injury.

Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?

Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation.

New directions in cardiac transplantation.

Hyposecretion, not hyperabsorption, is the basic defect of cystic fibrosis airway glands.

Executive summary for the National Heart, Lung, and Blood Institute Working Group on next generation ventricular assist devices for destination therapy.

Successful repair of blunt injury of aortic arch branches in the setting of bovine arch.

Successful bridge to transplant using the Berlin Heart left ventricular assist device in a 3-month-old infant.

Human tissue-engineered blood vessels for adult arterial revascularization.

Outcome analysis of donor gender in heart transplantation.

Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts.

Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts.

Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?

Aortic root aneurysm due to donor cystic medial degeneration after heart-lung transplantation.

Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse.

FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.

Influence of mast cells on outcome after heterotopic cardiac transplantation in rats.

Experimental orthotopic tracheal transplantation: The Stanford technique.

In vivo optical bioluminescence imaging of collagen-supported cardiac cell grafts.

Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells.

Positron emission tomography imaging of conditional gene activation in the heart.

Comment on "Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response".

Techniques for experimental heterotopic and orthotopic tracheal transplantations - When to use which model?

In vitro comparison of the biological effects of three transfection methods for magnetically labeling mouse embryonic stem cells with ferumoxides.

Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium.

Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model.

Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease.

Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis.

Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation.

In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.

Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function.

Pneumatic paracorporeal ventricular assist device in infants and children: initial Stanford experience.

Introducing the first polymer-free leflunomide eluting stent.

Prevention and inhibition but not reversion of chronic allograft vasculopathy by FK778.

Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection.

In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.

A novel platform device for rodent echocardiography.

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

Comparison of different adult stem cell types for treatment of myocardial ischemia.

Short hairpin RNA interference therapy for ischemic heart disease.

Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes.

Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells.

In vivo serial evaluation of superparamagnetic iron-oxide labeled stem cells by off-resonance positive contrast.

Effect of work-hour restriction on operative experience in cardiothoracic surgical residency training.

Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart.

A novel JAK3 inhibitor, R348, attenuates chronic airway allograft rejection.

Imaging survival and function of transplanted cardiac resident stem cells.

Imaging gene expression in human mesenchymal stem cells: from small to large animals.

Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process.

Manganese-guided cellular MRI of human embryonic stem cell and human bone marrow stromal cell viability.

Effects of cell number on teratoma formation by human embryonic stem cells.

Novel minicircle vector for gene therapy in murine myocardial infarction.

Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.

nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis.

Alternative technique for salvage of donor lungs with insufficient atrial cuffs.

Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium.

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells.

Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction.

The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice.

Mechanisms behind local immunosuppression using inhaled tacrolimus in preclinical models of lung transplantation.

Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction.

Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction.

IL-17 contributes to the development of chronic rejection in a murine heart transplant model.

A nonviral minicircle vector for deriving human iPS cells.

Non-volume-loaded heart provides a more relevant heterotopic transplantation model.

Review of heart-lung transplantation at Stanford.

Micro-CT for characterization of murine CV disease models.

MicroRNA-210 as a novel therapy for treatment of ischemic heart disease.

Sustained inhibition of epsilon protein kinase C inhibits vascular restenosis after balloon injury and stenting.

Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.

Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function.

Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors.

Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells.

Prevention of transplant coronary artery disease by prenylation inhibitors.

In vivo molecular MRI of cell survival and teratoma formation following embryonic stem cell transplantation into the injured murine myocardium.

αB-crystallin improves murine cardiac function and attenuates apoptosis in human endothelial cells exposed to ischemia-reperfusion.

Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds.

Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells.

Dual manganese-enhanced and delayed gadolinium-enhanced MRI detects myocardial border zone injury in a pig ischemia-reperfusion model.

Immunobiology of naïve and genetically modified HLA-class-I-knockdown human embryonic stem cells.

Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.

Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation.

Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival.

Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.

In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.

Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.

miR-29b Participates in Early Aneurysm Development in Marfan Syndrome.

Role of molecular imaging in stem cell therapy for myocardial restoration.

A novel cardioprotective agent in cardiac transplantation: metformin activation of AMP-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection.

Theranostic effect of serial manganese-enhanced magnetic resonance imaging of human embryonic stem cell derived teratoma.

Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease.

Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging.